FCM
Farallon Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192M | Buy |
5,767,466
+67,000
| +1% | +$2.23M | 0.83% | 34 |
|
|
2025
Q1 | $167M | Buy |
5,700,466
+26,000
| +0.5% | +$762K | 0.83% | 35 |
|
|
2024
Q4 | $186M | Buy |
5,674,466
+13,600
| +0.2% | +$447K | 0.83% | 37 |
|
|
2024
Q3 | $252M | Buy |
5,660,866
+6,364
| +0.1% | +$283K | 1.11% | 29 |
|
|
2024
Q2 | $244M | Buy |
5,654,502
+63,900
| +1% | +$2.76M | 1.05% | 27 |
|
|
2024
Q1 | $163M | Buy |
5,590,602
+1,423,000
| +34% | +$41.6M | 0.7% | 35 |
|
|
2023
Q4 | $92.8M | Buy |
4,167,602
+1,416,773
| +52% | +$31.6M | 0.43% | 46 |
|
|
2023
Q3 | $68.1M | Buy |
2,750,829
+62,000
| +2% | +$1.53M | 0.32% | 53 |
|
|
2023
Q2 | $76.1M | Buy |
2,688,829
+596,000
| +28% | +$16.9M | 0.38% | 51 |
|
|
2023
Q1 | $48.1M | Buy |
2,092,829
+67,000
| +3% | +$1.54M | 0.26% | 59 |
|
|
2022
Q4 | $56.9M | Buy |
2,025,829
+529,000
| +35% | +$14.9M | 0.34% | 61 |
|
|
2022
Q3 | $42.3M | Buy |
1,496,829
+163,817
| +12% | +$4.63M | 0.23% | 75 |
|
|
2022
Q2 | $29.6M | Hold |
1,333,012
| – | – | 0.16% | 82 |
|
|
2022
Q1 | $38.8M | Buy |
1,333,012
+76,434
| +6% | +$2.22M | 0.19% | 79 |
|
|
2021
Q4 | $41.3M | Buy |
1,256,578
+437,811
| +53% | +$14.4M | 0.21% | 71 |
|
|
2021
Q3 | $37.8M | Sell |
818,767
-341,233
| -29% | -$15.7M | 0.18% | 80 |
|
|
2021
Q2 | $63.9M | Sell |
1,160,000
-90,000
| -7% | -$4.96M | 0.26% | 59 |
|
|
2021
Q1 | $64.6M | Buy |
1,250,000
+250,000
| +25% | +$12.9M | 0.32% | 60 |
|
|
2020
Q4 | $43.3M | Sell |
1,000,000
-83,429
| -8% | -$3.61M | 0.26% | 68 |
|
|
2020
Q3 | $37.9M | Sell |
1,083,429
-166,571
| -13% | -$5.83M | 0.26% | 71 |
|
|
2020
Q2 | $66.9M | Hold |
1,250,000
| – | – | 0.54% | 48 |
|
|
2020
Q1 | $44.4M | Hold |
1,250,000
| – | – | 0.38% | 46 |
|
|
2019
Q4 | $59.7M | Buy |
+1,250,000
| New | +$59.7M | 0.4% | 45 |
|